Hannah Coleman
Researcher
University of Arkansas for Medical Sciences
faculty
Research Areas
Links
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Hannah Coleman's research program investigates the immune system's role in health and disease, with a particular focus on T-cell responses to human papillomavirus (HPV). She serves as PI on an NIH/National Cancer Institute grant totaling $727,264, aimed at understanding and enhancing T-cell responses to high-risk HPV types. Her work also extends to developing therapeutic vaccines for cervical intraepithelial neoplasia (CIN), as evidenced by her publications on peptide-based HPV therapeutic vaccines and their clinical trial outcomes.
Beyond HPV, Coleman's research interests encompass a range of medical applications. She has explored the use of physics-informed deep generative learning for quantitative assessment of the retina, indicating an interest in advanced computational methods for medical imaging. Additionally, her publications touch upon the predictive power of urine metabolites for lung cancer prognosis and the evaluation of DNA extraction protocols for studying cervical microbiota. Her scholarly contributions include 45 publications, with an h-index of 15 and over 765 citations, reflecting an active research presence.
Metrics
- h-index: 15
- Publications: 45
- Citations: 765
Selected Publications
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i> (2025) DOI
- Immune responses in a phase 2 clinical trial of peptide-based therapeutic human papillomavirus vaccine, PepCan, versus <i>Candida</i> adjuvant alone in treating cervical intraepithelial neoplasia 2/3. (2024) DOI
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or <i>Candida</i> adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3). (2023) DOI
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed (2021) DOI
- Evaluation of DNA extraction protocols from liquid-based cytology specimens for studying cervical microbiota (2021) DOI
Federal Grants 1 $727,264 total
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics